Singapore O&G (SGX:1D8) EBIT : S$9.98 Mil (TTM As of Dec. 2021)

View and export this data going back to 2015. Start your Free Trial

What is Singapore O&G EBIT?

Singapore O&G's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2021 was S$4.46 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2021 was S$9.98 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Singapore O&G's annualized ROC % for the quarter that ended in Dec. 2021 was 33.50%. Singapore O&G's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2021 was 213.82%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Singapore O&G's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2021 was 9.92%.

Singapore O&G EBIT Historical Data

The historical data trend for Singapore O&G's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Singapore O&G EBIT Chart

Singapore O&G Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

EBIT

Get a 7-Day Free Trial

9.93

10.93

0.80

10.96

9.98

Singapore O&G Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21
EBIT	Get a 7-Day Free Trial											-5.05	4.65	6.31	5.52	4.46

Competitive Comparison of Singapore O&G's EBIT

For the Medical Care Facilities subindustry, Singapore O&G's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Singapore O&G's EV-to-EBIT Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Singapore O&G's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Singapore O&G's EV-to-EBIT falls into.

Singapore O&G EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2021 adds up the semi-annually data reported by the company within the most recent 12 months, which was S$9.98 Mil.

Singapore O&G (SGX:1D8) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Singapore O&G's annualized ROC % for the quarter that ended in Dec. 2021 is calculated as:

	ROC % (Q: Dec. 2021 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Jun. 2021 )	+	Invested Capital (Q: Dec. 2021 ))	/ count )
=	8.898 * ( 1 - 12.43% )	/	( (19.401	+	27.112)	/ 2 )
=	7.7919786	/	23.2565
=	33.50 %

where

	Invested Capital		(Q: Jun. 2021 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	53.764	-	8.184	-	( 31.51	-	max(0, 10.279	-	36.458	+	31.51	))
=	19.401

	Invested Capital		(Q: Dec. 2021 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	57.786	-	3.318	-	( 35.765	-	max(0, 13.836	-	41.192	+	35.765	))
=	27.112

Note: The Operating Income data used here is two times the semi-annual (Dec. 2021) data.

2. Joel Greenblatt's definition of Return on Capital:

Singapore O&G's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2021 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Dec. 2021 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Jun. 2021		Q: Dec. 2021
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	8.912	/	( ( (4.436 + max(-3.849, 0))	+	(3.9 + max(-6.845, 0)) )	/	2 )
=	8.912	/	( ( 4.436	+	3.9 )	/	2 )
=	8.912	/	4.168
=	213.82 %

where Working Capital is:

	Working Capital		(Q: Jun. 2021 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(3.032	+	1.916	+	0)	-	(8.184	+	0	+	0.613)
=	-3.849

	Working Capital		(Q: Dec. 2021 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(2.015	+	2.129	+	1.283)	-	(3.318	+	0	+	8.954)
=	-6.845

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2021) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Singapore O&G's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Dec. 2021 )
	=	9.978	/	100.552
	=	9.92 %

Singapore O&G EBIT Related Terms

Thank you for viewing the detailed overview of Singapore O&G's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Singapore O&G (SGX:1D8) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Singapore O&G Ltd (SGX:1D8) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

229 Mountbatten Road, No. 02-02 Mountbatten Square, Singapore, SGP, 398007

Website

https://www.sog.com.sg

Singapore O&G Ltd is a Singapore based group of medical practioners dedicated to women's health and wellness in the obstetrics and gynaecology field. Its areas of specialisation are pregnancy care and delivery; the female reproductive system; gynaecological and breast cancer; skin and aesthetic treatments; and other ancillary medical services. The segments of the group are Obstetrics and Gynaecology, Cancer-related, Dermatology, Paediatrics and Corporate. It generates a majority of the revenue from the Obstetrics and Gynaecology Segment which relates to general obstetrics, labour and delivery, general gynaecology and surgery, female pelvic medicine, and urogynaecology and reconstructive surgery. All the operations of the organization are carried out in Singapore.

Singapore O&G (SGX:1D8) Headlines

No Headlines